$Xbiotech(XBIT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076080 Size: 5 KB 网页链接
$Xbiotech(XBIT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076084 Size: 5 KB 网页链接
$Xbiotech(XBIT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076081 Size: 5 KB 网页链接
$Xbiotech(XBIT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076082 Size: 5 KB 网页链接
$Xbiotech(XBIT)$ 8-K Current report, item 5.07 Accession Number: 0001171843-24-003541 Act: 34 Size: 186 KB 网页链接
$Xbiotech(XBIT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001171843-24-002746 Act: 34 Size: 2 MB 网页链接
$Xbiotech(XBIT)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-127578 Act: 34 Size: 753 KB 网页链接
$Xbiotech(XBIT)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-127584 Act: 34 Size: 396 KB 网页链接
$Xbiotech(XBIT)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-127586 Act: 34 Size: 1 MB 网页链接
$Xbiotech(XBIT)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001193125-24-127331 Act: 34 Size: 350 KB 网页链接